Cargando…
Successful desensitization in a boy with severe cow’s milk allergy by a combination therapy using omalizumab and rush oral immunotherapy
BACKGROUND: Rush oral immunotherapy (OIT) combined with omalizumab (OMB) has been reported to be an effective and safe treatment for severe milk allergies. However, no report has described long-term follow-up observations after OMB discontinuation. The purpose of this case report was to evaluate the...
Autores principales: | Takahashi, Masaya, Taniuchi, Shoichiro, Soejima, Kazuhiko, Hatano, Yasuko, Yamanouchi, Sohsaku, Kaneko, Kazunari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461908/ https://www.ncbi.nlm.nih.gov/pubmed/26064142 http://dx.doi.org/10.1186/s13223-015-0084-y |
Ejemplares similares
-
Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial
por: Takahashi, Masaya, et al.
Publicado: (2017) -
Two-weeks-sustained unresponsiveness by oral immunotherapy using microwave heated cow’s milk for children with cow’s milk allergy
por: Takahashi, Masaya, et al.
Publicado: (2016) -
Author Correction: Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial
por: Takahashi, Masaya, et al.
Publicado: (2018) -
Erratum to: Two-weeks-sustained unresponsiveness by oral immunotherapy using microwave heated cow’s milk for children with cow’s milk allergy
por: Takahashi, Masaya, et al.
Publicado: (2016) -
Immunotherapy for cow's milk allergy
por: Taniuchi, Shoichiro, et al.
Publicado: (2017)